Andes Biotechnologies
PrivateLast Round
Grant
Aug 7, 2017
Total Funding Raised
$18.05M
Company Overview
Andes Biotechnologies operates in Healthcare & Life Sciences and is based in Santiago. Its latest recorded funding round was a Grant round in August 2017.
Andes Biotechnologies is a drug discovery and development company that creates nucleic acid-based therapies for the treatment of solid tumor cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andes Biotechnologies Comparables
Compare Andes Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flamingo Therapeutics | 86% | |
| Amaroq Therapeutics | 81% | |
| TransCode Therapeutics, Inc. | 79% |
For institutional investors. Book with your work email.
Andes Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 7, 2017 | ||||
| Series B | Apr 16, 2015 | ||||
| Series A | Sep 9, 2010 | ||||
| Series A | Mar 15, 2010 |
For institutional investors. Book with your work email.
Andes Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austral Capital | Series B, Series A |
| Aurus Capital | Series B, Series A |
| Austral Capital Partners | Series A |
Andes Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Andes Biotechnologies's valuation, stock price, and market status.
Is Andes Biotechnologies a public or private company?
Andes Biotechnologies is a private company.
What is the current stock price of Andes Biotechnologies?
Andes Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Andes Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Andes Biotechnologies worth (valuation)?
Valuation information for Andes Biotechnologies is not publicly available.
Can I buy Andes Biotechnologies stock?
Andes Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Andes Biotechnologies's last funding round?
Andes Biotechnologies's most recent funding round was Grant on August 7, 2017.
Who are the main investors in Andes Biotechnologies?
Key investors in Andes Biotechnologies include Austral Capital, Aurus Capital, Austral Capital Partners.
Will Andes Biotechnologies IPO soon?
No public IPO plans have been announced for Andes Biotechnologies.
How can I track Andes Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Andes Biotechnologies's shares on secondary markets.